Hengrui Medicine sets up clinical research and development in Basel | BaselArea

“The Chinese life sciences company Hengrui Medicine is establishing a Swiss subsidiary in Basel. The European hub for clinical research and development will help the company to advance its innovative drugs, including cancer treatments.”

Read the full article @ BaselArea:

EY: Swiss companies are becoming less and less attractive to Chinese investors | moneycab

“The reluctance of Chinese companies to take over companies in Switzerland and Europe continues: in the first half of this year, only 81 takeovers and company holdings were counted across Europe – 27 percent less than in the same period last year when 113 European companies still had a Chinese owner. With hardly any large transactions, the investment volume declined significantly by 84 percent from $ 15.3 billion to $ 2.4 billion.”

Read the full article @ moneycab: